Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00068419 · ClinicalTrials.gov registry record · Phase 2

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

A Phase 2 study of Desmoid Tumor, sponsored by Children's Oncology Group.

Completed
Registry status
Phase 2
Development phase
70
Enrollment target
1
Study location

NCT00068419 is a Phase 2 study of Desmoid Tumor that has completed, run by Children's Oncology Group. The registered enrollment target is 70 participants, roughly in line with the 72-participant average among 4 other Desmoid Tumor trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00068419, a Phase 2 study of Desmoid Tumor, has completed, sponsored by Children's Oncology Group.

COMPLETED
Registry status
Phase 2
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

This phase II trial is studying how well giving sulindac together with tamoxifen works in treating patients with desmoid tumor. Sulindac may stop the growth of cancer cells by blocking the enzymes necessary for cancer cell growth. Hormone therapy using tamoxifen may fight cancer by blocking the use of estrogen. Combining sulindac with tamoxifen may kill more cancer cells.

Conditions Studied

Desmoid Tumor

Interventions

  • OTHER laboratory biomarker analysis
  • DRUG tamoxifen citrate
  • DRUG sulindac

Study Locations (1)

California

  • Children's Oncology Group - Monrovia

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2004-02
Est. Completion 2010-04-26
Phase Phase 2

Sponsor

Children's Oncology Group

342 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00068419

The ClinicalTrials.gov registry entry for NCT00068419 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 72-participant average among 4 other Desmoid Tumor trials with a reported enrollment target. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Desmoid Tumor appearing as the primary indexed condition, and to 3 interventions - of which laboratory biomarker analysis is the first listed.

NCT00068419 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00068419 about?

NCT00068419 is a clinical study titled "Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor". This phase II trial is studying how well giving sulindac together with tamoxifen works in treating patients with desmoid tumor. Sulindac may stop the growth of cancer cells by blocking the enzymes necessary for cancer cell growth. Hormone therapy using tamoxifen may fight cancer by blocking the use ...

What is the current status of trial NCT00068419?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2004-02. Estimated completion is 2010-04-26.

What conditions does trial NCT00068419 study?

This clinical trial studies the following conditions: Desmoid Tumor.

What interventions are being tested in trial NCT00068419?

The interventions under investigation include: laboratory biomarker analysis (OTHER), tamoxifen citrate (DRUG), sulindac (DRUG).

Who is sponsoring clinical trial NCT00068419?

This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00068419 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Desmoid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Desmoid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.